Similar articles

• Haight-Ashbury free clinics' drug detoxification protocols--Part 2: Opioid blockade.

  Galloway G, Hayner G. Galloway G, et al. J Psychoactive Drugs. 1993 Jul-Sep;25(3):251-2. doi: 10.1080/02791072.1993.10472276. J Psychoactive Drugs. 1993. PMID: 8258763 No abstract available.
• Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.

  Degenhardt L, Gibson A, Mattick RP, Hall W. Degenhardt L, et al. Drug Alcohol Rev. 2008 Jan;27(1):1-3. doi: 10.1080/09595230701711157. Drug Alcohol Rev. 2008. PMID: 18034375 No abstract available.
• Antagonist treatment of opioid withdrawal translational low dose approach.

  Mannelli P, Gottheil E, Van Bockstaele EJ. Mannelli P, et al. J Addict Dis. 2006;25(2):1-8. doi: 10.1300/J069v25n02_01. J Addict Dis. 2006. PMID: 16785213 Review.
• [Limited role of naltrexone in the treatment of opiate addiction].

  van Brussel GH. van Brussel GH. Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Ned Tijdschr Geneeskd. 2001. PMID: 11503313 Review. Dutch.
• [Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].

  Hensel M, Volk T, Kox WJ. Hensel M, et al. Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 May;34(5):261-8. doi: 10.1055/s-1999-188. Anasthesiol Intensivmed Notfallmed Schmerzther. 1999. PMID: 10372215 Review. German.